Neo-Soul Band Sweet Leda Takes a Stand for Gay Marriage with "Let Her Love Her"

Fans show support at sold-out album release show.

2011-04-04

ANNAPOLIS, MD, April 04, 2011 (Press-News.org) "I know a girl. She loves a girl. She is her world. She always hides the tears that she cries. Baby don't hide. If you disagree then just let them be," proclaims "Let Her Love Her," the second single off of rising neo-soul/pop band, Sweet Leda's recently-released album, Need the Music.

The song challenges prejudices and anti-gay sentiments by asserting that love is love. "Imagine if you finally found the right person, and you weren't even allowed to marry that person! Even worse, imagine that some people protested against you and demonstrated hate simply because of who you love," urges Sweet Leda Lead Singer Julie Cymek, who co-wrote the song with bandmates Jaime Horrigan (bass), Don Boyette (drums), and Omar El Dieahy (guitar). "The concept of love sparking hate breaks my heart. We are strong supporters of equality. If 'Let Her Love Her' causes even a single person to contemplate supporting same-sex marriage, I would consider it a victory."

The groove-induced song features a rap by Singer/Rapper/Percussionist Jay Crawdads from the group Higher Hands, a funk/soul group that has become a regular fixture on the Mid-Atlantic club and Festival circuits. In fact, it was during a show on that circuit that Crawdads and Leda had a chance encounter, which ultimately led to the collaboration.

"We wrote 'Let Her Love Her' in the fall of 2010, and I decided I wanted to write a rap for it," says Cymek. The problem was, as a rap-writing virgin, Cymek kept pushing the task to the back burner. That didn't stop the group from performing the almost-finished tune at a festival, which Crawdads and Higher Hands had attended. "Immediately after our set, Jay came up to us and said how special the song was to him and how he would love to be part of it in some way. It was a perfect fit! We asked him to write a rap for it, and a few months later, he came into the studio to record. None of us had any idea what he was going to say, but when he started rapping and singing, it was magic."

The band performed "Let Her Love Her" and other Need the Music tunes at their sold out Album Release Show, which was held on March 26th at Annapolis, MD's premier Rock 'n Roll club, The Whiskey. The event also featured an appearance by Crawdads and Higher Hands, along with Singer/Songwriter Christie Lenee.

"Let Her Love Her" and the entire Need the Music album are now available on the band's website and Facebook page, and can be purchased through iTunes.

About Sweet Leda
Based in Annapolis, MD, Sweet Leda is a rising star in the diverse Annapolis music community. With its rich blend of new school funk, soul, and pop, Sweet Leda's heartfelt original material has drawn comparisons to Joss Stone, Janis, Maroon 5, Supreme Beings of Leisure, and Edie Brickell, while garnering its very own stylistic label: "Sexy smooth rock and groove."

For more information about Sweet Leda, please email Jaime Horrigan at jaime@sweetleda.com or call 410.507.2711.

Official Website: http://www.sweetleda.com
Facebook: http://www.facebook.com/pages/Sweet-Leda/170802465076
Myspace: http://www.myspace.com/sweetleda
iTunes: http://itunes.apple.com/us/album/need-the-music/id429247653

ELSE PRESS RELEASES FROM THIS DATE:

Are ICDs up to par with patients living longer?

2011-04-04

Most patients with ischemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM) who have an implantable cardioverter-defibrillator (ICD) now live more than seven years and those ICD patients with hereditary heart disease can live for decades, based on a scientific paper that will be presented at the American College of Cardiology (ACC) Scientific Sessions in New Orleans, April 1-3. With ICM, the left ventricle of the patient's heart pumps blood poorly due to coronary artery disease. With DCM, the heart has become weakened and enlarged, and cannot pump blood efficiently. ...

Chest pain med is effective for refractory angina, but adherence problematic

2011-04-04

Ranolazine (Ranexa, Gilead) is an effective anti-anginal therapy in patients with refractory angina; however, at one year only 59 percent of patients remained on the drug, according to a scientific poster that will be presented at the American College of Cardiology (ACC) Scientific Sessions in New Orleans, April 1-3. Patients with refractory angina, who have chronic chest pain but are not candidates for revascularization, have limited therapeutic options and significant limitations in their quality of life, the study authors wrote. Conversely, patients with chronic angina ...

Hartford Students Receive a $78,000 Gift of Success - The Birch Group, LLC and TTI Performance Systems Donate Their Skills and Talent to the Academy

2011-04-04

Each of the 400 students at Hartford Public High School Engineering and Green Technology Academy received a key to success in the form a DISC Behavioral and Workplace Motivator Assessment courtesy of Bill Bonnstetter, CEO and founder of TTI Performance Systems, Ltd. in Scottsdale, AZ and John Birch, founder and president of The Birch Group, LLC, a management consultant firm based in New Britain, CT. TTI Performance Systems generously provided the assessments and The Birch Group administered and coordinated the reports as well as provided training to the students. The value ...

Protocol-driven heart attack care proves effective and contagious

2011-04-04

The implementation of acute heart attack or ST-elevation myocardial infarction (STEMI) guidelines, protocols and standing orders in Minnesota community hospitals without cardiac catheterization labs has dramatically improved since 2003, according to a scientific poster that will be presented at the American College of Cardiology (ACC) Scientific Sessions in New Orleans, April 1-3. Since the 1990s, the American College Cardiology (ACC)/American Heart Association (AHA) STEMI guidelines recommended that all hospitals develop protocols and standing orders (reperfusion strategy, ...

Serum test could identify lung cancer in people who never smoked

2011-04-04

ORLANDO, Fla. — A panel of biomarkers appears to be able to identify the presence of lung cancer in the blood samples of people who have never smoked, according to data presented at the AACR 102nd Annual Meeting 2011, held here April 2-6. While lung cancer has long been linked to smoking, approximately one-fourth of patients with lung cancer have never smoked. Researchers are working on ways to identify the presence of lung cancer in these patients. Charlie Birse, Ph.D., associate director of product development at Celera Corporation, and colleagues are investigating ...

Protein test detects early-stage, asbestos-related pulmonary cancer

2011-04-04

ORLANDO, Fla. — Researchers investigating a novel biomarker test believe it is the most accurate yet in detecting proteins secreted from tumors caused by exposure to asbestos. Study results of this aptamer proteomic technology were presented at the AACR 102nd Annual Meeting 2011, held April 2-6. In a blinded test performed under the auspices of the National Cancer Institute's Early Detection Research Network Biomarker Discovery Lab, the proteomic assay could detect 15 of 19 cases of malignant pleural mesothelioma that were in stage 1 or stage 2, making the test about ...

Breast milk may provide a personalized screen of breast cancer risk

2011-04-04

ORLANDO, Fla. — Breast cancer risk can be assessed by examining the epithelial cells found in breast milk, according to preliminary study results presented at the AACR 102nd Annual Meeting 2011, held April 2-6. This screening method has the potential to provide a personalized assessment of breast cancer risk, said lead researcher Kathleen F. Arcaro, Ph.D., associate professor of veterinary and animal sciences at the University of Massachusetts Amherst. Given that roughly 80 percent of women give birth, this screen would also cover a large percentage of the female population. ...

Nicotine does not promote lung cancer growth in mouse models

2011-04-04

ORLANDO, Fla. — Nicotine at doses similar to those found in most nicotine replacements therapies did not increase lung cancer tumor incidence, frequency or size, according to results of a mouse study presented at the AACR 102nd Annual Meeting 2011, held here April 2-6. "If you take our data and combine it with epidemiological data from Europe, even in people who quit smoking and maintain the use of nicotine replacement therapy for months or years, there does not appear to be increased lung cancer incidence," said Phillip A. Dennis, M.D., Ph.D., senior investigator at ...

Aspirin may lower the risk of pancreatic cancer

2011-04-04

ORLANDO, Fla. — The use of aspirin at least once per month is associated with a significant decrease in pancreatic cancer risk, according to results of a large case-control study presented at the AACR 102nd Annual Meeting 2011, held here April 2-6. Xiang-Lin Tan, Ph.D., M.D., a research fellow at Mayo Clinic in Rochester, Minn., said the findings from this large collaborative study are preliminary and do not encourage widespread use of aspirin for this purpose. "The results are not meant to suggest everyone should start taking aspirin once monthly to reduce their risk ...

Lung cancer risk rises in the presence of HPV antibodies

2011-04-04

ORLANDO, Fla. — Researchers with the International Agency for Research on Cancer (IARC) have found that people with lung cancer were significantly more likely to have several high-risk forms of human papillomavirus (HPV) antibodies compared to those who did not have lung cancer. These results, which were presented at the AACR 102nd Annual Meeting 2011, held April 2-6, indicate that HPV antibodies are substantially increased in people with lung cancer. Devasena Anantharaman, Ph.D., postdoctoral fellow in the Genetic Epidemiology Group at the IARC in Lyon, France, and ...

Neo-Soul Band Sweet Leda Takes a Stand for Gay Marriage with "Let Her Love Her"

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: